When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AZNCF - IPO Update: CureVac Readies Plans For U.S. IPO
AstraZeneca Plc
Quick Take
CureVac (CVAC) intends to raise $200 million from the sale of its common stock in an IPO, plus another $118 million from a concurrent private placement, according to an amended registration statement.
The company is advancing a number of drug development and gene therapy programs for large and rare diseases.
CVAC says its Phase 3 trial for a Covid-19 vaccine will publish results in Q4 2020 and the IPO enjoys significant investor support, so the IPO is intriguing.
Company & Technology
Tubingen, Germany-based CureVac was founded to create mRNA-mediated treatment